annual FCF:
-$529.63M-$608.00K(-0.11%)Summary
- As of today (May 29, 2025), BBIO annual free cash flow is -$529.63 million, with the most recent change of -$608.00 thousand (-0.11%) on December 31, 2024.
- During the last 3 years, BBIO annual FCF has risen by +$16.55 million (+3.03%).
- BBIO annual FCF is now -1193.30% below its all-time high of -$40.95 million, reached on December 31, 2017.
Performance
BBIO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$200.83M-$2.27M(-1.14%)Summary
- As of today (May 29, 2025), BBIO quarterly free cash flow is -$200.83 million, with the most recent change of -$2.27 million (-1.14%) on March 31, 2025.
- Over the past year, BBIO quarterly FCF has increased by +$20.20 million (+9.14%).
- BBIO quarterly FCF is now -377.94% below its all-time high of $72.26 million, reached on June 30, 2024.
Performance
BBIO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$509.44M+$20.20M(+3.81%)Summary
- As of today (May 29, 2025), BBIO TTM free cash flow is -$509.44 million, with the most recent change of +$20.20 million (+3.81%) on March 31, 2025.
- Over the past year, BBIO TTM FCF has increased by +$96.29 million (+15.90%).
- BBIO TTM FCF is now -1437.78% below its all-time high of -$33.13 million, reached on March 31, 2018.
Performance
BBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BBIO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | +9.1% | +15.9% |
| 3 y3 years | +3.0% | -24.4% | +8.2% |
| 5 y5 years | -106.7% | -127.2% | -80.0% |
BBIO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | +3.0% | -377.9% | +9.1% | -24.7% | +15.9% |
| 5 y | 5-year | -106.7% | +3.0% | -377.9% | +9.1% | -80.0% | +15.9% |
| alltime | all time | -1193.3% | +3.0% | -377.9% | +9.1% | -1437.8% | +15.9% |
BBIO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$200.83M(+1.1%) | -$509.44M(-3.8%) |
| Dec 2024 | -$529.63M(+0.1%) | -$198.56M(+8.9%) | -$529.63M(+16.1%) |
| Sep 2024 | - | -$182.30M(-352.3%) | -$456.32M(+8.7%) |
| Jun 2024 | - | $72.26M(-132.7%) | -$419.68M(-30.7%) |
| Mar 2024 | - | -$221.03M(+76.5%) | -$605.72M(+14.5%) |
| Dec 2023 | -$529.03M(+24.2%) | -$125.25M(-14.0%) | -$529.03M(+6.3%) |
| Sep 2023 | - | -$145.66M(+28.0%) | -$497.82M(+2.0%) |
| Jun 2023 | - | -$113.78M(-21.2%) | -$488.08M(+19.4%) |
| Mar 2023 | - | -$144.33M(+53.5%) | -$408.65M(-4.0%) |
| Dec 2022 | -$425.81M(-22.0%) | -$94.04M(-30.8%) | -$425.81M(-9.1%) |
| Sep 2022 | - | -$135.92M(+295.6%) | -$468.20M(-5.5%) |
| Jun 2022 | - | -$34.35M(-78.7%) | -$495.30M(-10.7%) |
| Mar 2022 | - | -$161.49M(+18.4%) | -$554.95M(+1.6%) |
| Dec 2021 | -$546.18M | -$136.43M(-16.3%) | -$546.18M(+7.5%) |
| Sep 2021 | - | -$163.02M(+73.4%) | -$508.16M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$94.00M(-38.5%) | -$477.37M(+1.2%) |
| Mar 2021 | - | -$152.73M(+55.2%) | -$471.56M(+15.8%) |
| Dec 2020 | -$407.23M(+58.9%) | -$98.41M(-25.6%) | -$407.23M(+6.0%) |
| Sep 2020 | - | -$132.23M(+49.9%) | -$384.27M(+27.1%) |
| Jun 2020 | - | -$88.19M(-0.2%) | -$302.42M(+6.8%) |
| Mar 2020 | - | -$88.40M(+17.2%) | -$283.06M(+10.5%) |
| Dec 2019 | -$256.23M(+65.5%) | -$75.45M(+49.8%) | -$256.23M(+12.4%) |
| Sep 2019 | - | -$50.38M(-26.8%) | -$227.93M(+5.3%) |
| Jun 2019 | - | -$68.83M(+11.8%) | -$216.48M(+18.1%) |
| Mar 2019 | - | -$61.57M(+30.6%) | -$183.26M(+18.4%) |
| Dec 2018 | -$154.82M(+278.1%) | -$47.16M(+21.1%) | -$154.82M(+43.8%) |
| Sep 2018 | - | -$38.93M(+9.3%) | -$107.67M(+56.6%) |
| Jun 2018 | - | -$35.61M(+7.5%) | -$68.74M(+107.5%) |
| Mar 2018 | - | -$33.13M | -$33.13M |
| Dec 2017 | -$40.95M | - | - |
FAQ
- What is BridgeBio Pharma annual free cash flow?
- What is the all time high annual FCF for BridgeBio Pharma?
- What is BridgeBio Pharma annual FCF year-on-year change?
- What is BridgeBio Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly FCF year-on-year change?
- What is BridgeBio Pharma TTM free cash flow?
- What is the all time high TTM FCF for BridgeBio Pharma?
- What is BridgeBio Pharma TTM FCF year-on-year change?
What is BridgeBio Pharma annual free cash flow?
The current annual FCF of BBIO is -$529.63M
What is the all time high annual FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high annual free cash flow is -$40.95M
What is BridgeBio Pharma annual FCF year-on-year change?
Over the past year, BBIO annual free cash flow has changed by -$608.00K (-0.11%)
What is BridgeBio Pharma quarterly free cash flow?
The current quarterly FCF of BBIO is -$200.83M
What is the all time high quarterly FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly free cash flow is $72.26M
What is BridgeBio Pharma quarterly FCF year-on-year change?
Over the past year, BBIO quarterly free cash flow has changed by +$20.20M (+9.14%)
What is BridgeBio Pharma TTM free cash flow?
The current TTM FCF of BBIO is -$509.44M
What is the all time high TTM FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM free cash flow is -$33.13M
What is BridgeBio Pharma TTM FCF year-on-year change?
Over the past year, BBIO TTM free cash flow has changed by +$96.29M (+15.90%)